chapter 18 psychoactive substance use disorders: drugs

19
Chapter 18 Psychoactive Substance Use Disorders: Drugs

Upload: camron-horton

Post on 26-Dec-2015

221 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Chapter 18

Psychoactive Substance Use Disorders: Drugs

Page 2: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Description of the Disorder

• Drug use is a prevalent and pervasive issue in the United States

• SUDs incur a huge cost to society.– $484 billion annually

• In 2008, about 22.2 million individuals were classified with substance dependence or abuse as defined by DSM-IV-TR

• Associated with increased risk-taking behavior

Page 3: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Clinical Picture

• SUDs may result from single or multiple substances • Classes of drugs:– Cannabinoids– Hallucinogens– Depressants– Opioids– Stimulants– Inhalants– Dissociative anesthetics

Page 4: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Diagnostic Considerations

• Maladaptive pattern of behaviors related to substance use

• Four categories of maladaptive behaviors:1. Impaired control2. Social impairment3. Risky use4. Pharmacological criteria

Page 5: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Impaired Control

• Unsuccessful attempts to cut back• Taking more than planned• Longer duration of use• Craving or a perceived need to engage in

substance use• Craving may consume one’s thoughts

Page 6: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Social Impairment

• Inability to carry out needs of daily life• Failing to fulfill obligations• Engaging in substance use rather than social

activities• Persistent use in spite of negative social

impact

Page 7: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Risky Use

• Continued use when known danger exists• Dangerous situation• Likely physiological consequences

Page 8: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Pharmacological Criteria

• Tolerance: State that develops wherein the user needs progressively larger doses of the drug to feel the desired effect

• Withdrawal: Physical response to specific substances that can occur after extended, consistent use

Page 9: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Epidemiology

• 8% of Americans over the age of 12 report illicit drug use– Rates of marijuana use are rising, particularly

among youth • 1.8 million admissions to treatment in 2007– Largely for alcohol use or alcohol and a secondary

substance

Page 10: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Psychological and Biological Assessment

• Important to assess for other psychological disorders, given the high rate of comorbidity– Assessing for daily impairment and readiness to change

may provide useful information for treatment – Functional analysis may also be beneficial – Outcome assessments should be performed to monitor

progress • Biological methods include:– Urinalysis– Blood, saliva, and hair testing

Page 11: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Etiological Considerations

• Behavioral genetics– Genetic factors account for a significant portion of the

variance in substance use disorders– Genetic influence appears to increase over time until middle

adulthood• Molecular genetics– Strongest single-gene effects have been found for

polymorphisms of the ALDH and ADH genes in Asian samples– GABA receptor genes on chromosome 4 and substance abuse– Polymorphisms in dopamine receptor genes

Page 12: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Etiological Considerations cont.

• Gene–environment interactions– Stress, the DRD2 gene, and alcohol dependence– MAOA, childhood maltreatment, and alcohol use

problems– More environmental measures need to be utilized

in genetic studies

Page 13: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Etiological Considerations cont.

• Brain reward circuits are associated with increased risk– Enhanced activity in regions often associated with reward

systems• Chronic drug administration is associated with alterations in this

system, including decreased extracellular dopamine and reduced D2 receptor availability

• Brain stress circuits– Greater reactivity in the HPA axis of rats has been

associated with greater self-administration of addictive substances

– HPA axis activation also associated with increased dopaminergic neurotransmission in reward circuits

Page 14: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Etiological Considerations cont.

• Neuroadaptation in reward and stress circuitry– Reward and stress circuits become dysregulated

with chronic drug use, which creates a state of negative affect when the drug is not used, thus increasing the reinforcing properties of the drug

– Users have difficulty dealing with stress when the circuit becomes dysregulated

Page 15: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Etiological Considerations cont.

• Learning and modeling– Drugs are reinforcers• Use increases in environments devoid of alternative

forms of reinforcement

• Life events– Chronic stress contributes to both initiation and

maintenance of drug use – Emotional stressors associated with greater

vulnerability to SUDs

Page 16: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Etiological Considerations cont.

• Cognitive influences– Expectancies• Relationship between positive expectancies and

substance use• Negative expectancies associated with maintaining

abstinence from use

– Executive functioning• Drug use alters executive functions (e.g., decision

making and attention)

Page 17: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Etiological Considerations cont.

• Sex– Men and women differ in their pathways to drug

addiction • Women are less likely to have an SUD, and onset is often later

in life; however, they become dependent more quickly and experience more severe consequences

• Men and women have different barriers to treatment

• Racial/ethnic factors– Minorities in inner cities are particularly vulnerable to

drug use – Reduced access/use of community services for treatment

Page 18: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Course and Prognosis

• Development and progression of substance use among adolescents is debated in the literature– “Gateway theory”

• Risk factors include age of initiation and frequency of use during adolescence– Others include mood/anxiety disorders and certain

personality disorders• Recovery is notoriously difficult once an SUD is

present

Page 19: Chapter 18 Psychoactive Substance Use Disorders: Drugs

Course and Prognosis

• Treatment outcome– Influenced by:• Severity of addiction• Individual characteristics• Length of stay in treatment

– Recovery is a long-term process